Form D · Biotechnology
BluDiagnostics, Inc.
Madison, WI · CIK 0001663674
Offering snapshot reported May 31, 2018 · SEC filing
- Reported sold
- $3.4M Offering amount: $3.4M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 15, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 31, 2018 | Initial | $3,400,000 | No comparison | 2 | SEC filing |
| Feb 4, 2016 | Amendment | $1,150,000 | $550,000vs Jan 19, 2016 | 14 | SEC filing |
| Jan 19, 2016 | Initial | $600,000 | No comparison | 9 | SEC filing |
Offering details
- Securities
- Debt
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-313574
Source: Form D, filed May 31, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Sarah Katherine Brenner | Director, Executive |
| Jodi L. Schroll | Director, Executive |
| Douglas B. Weibel | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
123 N. Blount Street Suite 307
Madison, WI, 53703
Madison, WI, 53703